Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19
Jeffrey S. Berger(New York University), Leora I. Horwitz(New York Academy of Medicine), Samrachana Adhikari(Satakunta University of Applied Sciences), Shadi Yaghi, Nancy Amoroso(Pulmonary and Critical Care Associates), James Slater(New York University), Christopher M. Petrilli(New York University), James M. Horowitz(Horse Hospital), Harmony R. Reynolds(New York University), Sam Parnia(NYU Langone Health), Eugene Yuriditsky(New York University), Yindalon Aphinyanaphongs(NYU Langone Health), Judith S. Hochman(Columbia University Irving Medical Center), Emma Simon(Tokyo Health Care University), Meng Cao(GGG (France)), Ronald Goldenberg, Dennis Kunichoff(Population Council), Alexander Hindenburg(Winthrop-University Hospital), Tania Ahuja(NYU Langone Health)
Cited by 193
Related Papers
SARS-CoV-2 and Stroke in a New York Healthcare System
|Stroke|2020|749
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
|New England Journal of Medicine|2016|628
Health effects of diesel exhaust emissions
|European Respiratory Journal|2001|594
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
|Bristol Research (University of Bristol)|2021|589